Nutritional Intervention After Total Gastrectomy for Gastric Cancer
NCT07920705, Not applicable, Completed, Hanoi Medical University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Nutritional Intervention After Total Gastrectomy for Gastric Cancer | ClinicalTrials.gov |
| NCT number | NCT07920705 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 84 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Hanoi Medical University | ClinicalTrials.gov |
| Conditions | Gastric Cancer (GC) | ClinicalTrials.gov |
| Interventions | Oral Nutritional Supplementation (ONS) and Structured Dietary Counseling, Standard Perioperative Care | ClinicalTrials.gov |
| First posted | 2026-11-06 | ClinicalTrials.gov |
| Last updated | 2026-11-09 | ClinicalTrials.gov |
Registered outcomes 17
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Body Weight | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Participant body weight measured in kilograms (kg) under fasting conditions using a calibrated body composition balance. | ClinicalTrials.gov |
| Primary | Body Mass Index (BMI) | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Calculated as body weight in kilograms divided by height in meters squared (kg/m²). | ClinicalTrials.gov |
| Primary | Skeletal Muscle Mass | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Total skeletal muscle mass measured in kilograms (kg) using multi-frequency bioelectrical impedance analysis (BIA; Tanita body composition analyzer). | ClinicalTrials.gov |
| Primary | Handgrip Muscle Strength | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Upper-body muscle strength measured in kilograms (kg) using a calibrated digital hand dynamometer. | ClinicalTrials.gov |
| Primary | Time to First Flatus | From surgical completion up to 14 days postoperatively (during inpatient stay) | Time elapsed from surgical wound closure to the first recorded passage of flatus (bowel movement), measured in hours as a clinical indicator of gastrointestinal motility restoration. | ClinicalTrials.gov |
| Primary | Time to Oral Feeding Initiation | From surgical completion up to 14 days postoperatively (during inpatient stay) | Time elapsed from completion of surgery to the first successful and tolerated resumption of oral clear liquid feeding, recorded in hours. | ClinicalTrials.gov |
| Primary | Postoperative Length of Hospital Stay | From day of surgery up to discharge (up to 30 days) | Total duration of hospitalization, calculated as the number of days elapsed from surgery to hospital discharge. | ClinicalTrials.gov |
| Primary | Postoperative Complication Rate | Up to 30 days postoperatively | Incidence of surgical and medical post-operative complications (e.g., anastomotic leak, wound infection, pneumonia) recorded within 30 days following total gastrectomy. | ClinicalTrials.gov |
| Secondary | Mid-Upper Arm Circumference (MUAC) | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Anthropometric indicator of arm skeletal muscle and subcutaneous fat reserves measured in centimeters (cm) using a non-stretch tape. | ClinicalTrials.gov |
| Secondary | Body Fat Percentage | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Proportion of total body mass composed of adipose tissue (%), measured via multi-frequency bioelectrical impedance analysis (BIA). | ClinicalTrials.gov |
| Secondary | Postoperative Malnutrition Rate Evaluated by GLIM Criteria | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Proportion of participants diagnosed with malnutrition according to the Global Leadership Initiative on Malnutrition (GLIM) consensus framework, combining phenotypic (weight loss, low BMI) and etiologic criteria (reduced food intake, systemic inflammation). | ClinicalTrials.gov |
| Secondary | Prognostic Nutritional Index (PNI) Score and Abnormal PNI Rate | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | PNI score calculated as: Serum Albumin (g/L) + 5 × Total Lymphocyte Count (10⁹/L). Abnormal PNI rate is defined as the proportion of participants with PNI \< 45.0. | ClinicalTrials.gov |
| Secondary | Controlling Nutritional Status (CONUT) Score and High-Risk Rate | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Derived from serum albumin (g/dL), total cholesterol (mg/dL), and total lymphocyte count (/mm³), ranging from 0 to 12. High-risk CONUT rate is defined as the proportion of participants with a score ≥ 5. | ClinicalTrials.gov |
| Other | Serum Albumin Concentration | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Circulating serum albumin level measured in grams per liter (g/L) or grams per deciliter (g/dL) as a biomarker of visceral protein reserves. | ClinicalTrials.gov |
| Other | Serum Total Protein Concentration | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Total circulating serum protein level measured in grams per liter (g/L) from venous blood samples. | ClinicalTrials.gov |
| Other | Total Lymphocyte Count (TLC) | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | Absolute peripheral blood lymphocyte count (10⁹/L or cells/mm³) obtained from complete blood count (CBC) to reflect cellular immune status. | ClinicalTrials.gov |
| Other | Blood Hemoglobin Concentration | Baseline (pre-operative, T0) and 1 month post-surgery (T1) | irculating blood hemoglobin level measured in grams per deciliter (g/dL) as a measure of anemia and red blood cell capacity. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)